Company had minimal pricing governance process in place which was leading to sub-optimal pricing in ...
Read moreThe client required expert operational pricing support and insights during a company restructure whi...
Read moreOur client had in-licenced a hospital drug that they were seeking to launch in the EU, following a r...
Read moreOur client was struggling to understand the value of their product (a single-use treatment for an ul...
Read moreWe discuss gene therapy pricing and reimbursement, manufacturing methods, analytical analysis, and k...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreFrom 2016, the Innovation Fund has served as an instrument of central health policy to promote new f...
Read moreThis law is projected to have a large impact on the pharmaceutical industry and pharmacies nationwid...
Read moreWe discuss the advantages and disadvantages of using international reference pricing for consistent ...
Read moreWe compare the rates of positive reimbursement decisions in England and EU4 for orphan drugs approve...
Read more